|
Match
|
Document |
Document Title |
|
|
7629442 |
Acid soluble proteins from micellar casein
The present invention relates to a milk fraction obtainable by acidification of micellar casein and separation from precipitated casein named acid soluble protein from micellar casein. It was found...
|
|
|
7588752 |
Antimicrobial peptides
The present invention provides antimicrobial peptides. The peptides are non-glycosylated, less than about 100 amino acids in length, and include an amino acid sequence selected from:...
|
|
|
7566742 |
Phosphoprotein preparations for bioactive metal ion delivery and teeth remineralisation
The invention provides, in one aspect, compositions for delivering a bioactive metal ion to a mammal, the compositions comprising (a) an effective amount of a source of the bioactive metal ion, (b)...
|
|
|
7312193 |
Calcium phosphopeptide complexes
Phosphopeptides containing the Ser(P) cluster sequence motif Ser(P)-Ser(P)-Ser(P)-Glu-Glu- can stabilize their own weight in amorphous calcium phosphate (ACP) [Ca 3 (PO 4 ) 1.87 (HPO 4 ) 0.2 xH 2...
|
|
|
7129210 |
Tissue adhesive sealant
A tissue adhesive sealant includes a cross-linkable protein in a solution that when combined with a cross-linking agent solution including an aldehyde and amino acid containing species reactive...
|
|
|
7122635 |
Method and composition for angiogenesis inhibition
The invention describes methods for inhibiting angiogenesis in a tissue by administering an antagonist that specifically binds to a proteolyzed or denatured collagen but not to native triple...
|
|
|
7091320 |
Product derived from milk substantially free of beta casein from non-human mammals and relative use
The present invention is related to a product derived from milk, substantially free of beta casein from non-human mammals. The invention is also related to the use of such a product especially in...
|
|
|
6849593 |
Bifidogenic peptides
Pepetides having bifidogenic properties are obtainable by the process of adding proteases to cow'milk or human milk, followed by incubation, centrifugation, acidification, purification by reverse...
|
|
|
6838431 |
Nutritional intervention composition containing a source of proteinase inhibitor extending post meal satiety
The invention relates to a nutritional intervention composition in powder form that is taken before a meal and that extends post meal satiety. The compositions of the invention are comprised of at...
|
|
|
6824783 |
Methods for inhibition of membrane fusion-associated events, including HIV transmission
The present invention relates to peptides which exhibit potent anti-retroviral activity. The peptides of the invention comprise DP178 (SEQ ID:1) peptide corresponding to amino acids 638 to 673 of...
|
|
|
6797810 |
Method for isolation and modification of proteins
A method for modification and isolation of a protein is provided. The method includes the steps of providing a protein selected from the group consisting of whey and soy proteins; providing a...
|
|
|
6750203 |
Product derived from milk substantially free of beta casein from non-human mammals and relative use
The present invention is related to a product derived from milk, substantially free of beta casein from non-human mammals. The invention is also related to the use of such a product especially in...
|
|
|
6656690 |
Mass spectrometric methods for biomolecular screening
The present invention provides methods for the determination of the structure of biomolecular targets, as well as the site and nature of the interaction between ligands and biomolecular targets....
|
|
|
6624144 |
Matrix metalloproteinase inhibitors and down-regulators
The present invention relates to novel matrix metalloproteinase (MMP) inhibitors and down-regulators, to a process for the preparation of these inhibitors, to pharmaceutical compositions comprising...
|
|
|
6599874 |
Protein complex from ion-exchange chromatography of casein for treatment of bacterial infections
Antibacterial protein complexes designated as Anti-adhesive Lactalbumin Like Protein (ALLP) are obtained by ion-exchange chromatography of casein and alpha-lactalbumin. Casein isolated from human...
|
|
|
6579849 |
Antibiotic peptides from bovine milk
A peptide having the amino acid sequence H 2 N—X 1 —R—X 3 —X 2 —COOH (formula I) wherein X 1 is either zero or X 1 and/or X 2 are a residue representing at least five amino acid...
|
|
|
6558717 |
Method for the sequential precipitation of casein and calcium phosphate from a milk source
A method for isolating casein and calcium phosphate as separate products from a milk source, comprising the steps of: a) contacting the milk source with carbon dioxide under pressure in order to...
|
|
|
6555659 |
Process for isolating glycomacropeptide from dairy products with a phenylalanine impurity of 0.5% w/w
The present invention is related to a method for the purification of glycomacropeptide (GMP) with an amino acid composition containing no greater that 0.5% (w/w) phenylalanine, comprising the steps...
|
|
|
6537760 |
Receptor binding assay for detecting TSH-receptor auto-antibodies
In a competitive receptor binding assay for detecting TSH-receptor auto-antibodies in a biological sample, the sample is reacted in a reaction mixture which contains (i) a TSH-receptor or...
|
|
|
6521591 |
Pharmaceutical composition for muscular anabolism
A pharmaceutical composition suitable for enhancing muscular anabolism contains, per daily dose, at least 5 mg of anabolic initiators comprising anabolic growth factors, at least 0.12 g of protein...
|
|
|
6506732 |
Enzymatic hydrolysate of milk proteins
The present invention relates to a mixture of soluble hydrophobic peptides of an enzymatic hydrolysate of milk having skin hydrating properties and percutaneous absorption levels of 4 to 5%. The...
|
|
|
6495344 |
Phenylalanine-free protein and DNA coding therefor
A DNA molecule coding for a food protein, such as ovalbumin or casein, modified so that the codons for phenylalanine have been omitted or replaced by codons for one or more other metabolisable...
|
|
|
6462181 |
Process for preparing a kappa-caseino glycomacropeptide or a derivative thereof
Improved process for preparing a kappa-caseino glycomacropeptide which comprises adjusting the pH of a solution of a milk starting material to below 4, cold ultrafiltration and concentration of the...
|
|
|
6355612 |
Protein material for slow digestion and its use
The subject of the invention is the use of a protein material whose rate of digestion has been reduced, for the preparation of an enteral composition which makes it possible to modulate the...
|
|
|
6270827 |
Infant formula compositions and method of making
Compositions containing human milk proteins, including the so-called host resistance factors of human milk, prepared by chemically synthesizing the human milk proteins or by genetic engineering...
|
|
|
6180761 |
Casein from Korean cattle
A new casein is disclosed isolated from the milk of Korean cattle with a β-casein A 1 H genotype. Amino acid sequence analysis of the casein revealed a length of 209 amino acids, where, in...
|
|
|
6121421 |
Methods for isolating recombinant β-casein
The invention provides a method for isolating a protein, specifically β-casein, recombinantly produced in cells that have been genetically engineered to produce the protein. The method involves...
|
|
|
6080844 |
Process for the recovery and purification of a recombinant protein from a cell
The present invention involves a process of purifying and recovering a recombinant protein from a suspension of cells. The process of the present invention involves extracting a recombinant protein...
|
|
|
6020015 |
Infant formula compositions and nutrition containing genetically engineered human milk proteins
Compositions containing human milk proteins, including the so-called host resistance factors of human milk, prepared by chemically synthesizing the human milk proteins or by genetic engineering...
|
|
|
5968901 |
Antibacterial composition
The present invention relates to a use of casein derived from milks, preferably human milk, and porcine milk, for the preparation of a substrate for the prophylactic and/or therapeutic treatment of...
|
|
|
5952009 |
Methods for preventing the transmission of or treating patients infected with herpesvirus
A method of preventing the transmission of or treating herpesvirus, such as herpes simplex virus infection, or Chlamydia trachomatis comprising administering to a patient a composition which...
|
|
|
5942254 |
Phosphorylated recombinant human β-casein expressed in a bacterial system
The present invention provides a plasmid containing a promoter sequence, a nucleotide sequence encoding an exogenous protein, and a nucleotide sequence encoding an enzyme capable of modifying the...
|
|
|
5834427 |
Casein phosphopeptide, casein containing same and process for the preparation thereof
The present invention relates to a purified casein phosphopeptide(CPP) having a novel amino acid sequence and a purified casein including same wherein the 25th Arg from N-terminal in a conventional...
|
|
|
5807702 |
Method for expressing phosphorylated recombinant human β-casein in a bacterial system
The present invention provides a method of producing phophorylated, recombinant human β-casein having 3 to 5 phosphates in a bacterial cell using a single vector containing in tandem both the...
|
|
|
5780439 |
Whey protein hydrolysates and mixtures thereof with casein and/or soy protein hydrolysates
A whey protein hydrolysate is described which is free of allergenics while preserving the structures susceptible of exerting anticipatory regulations to maximize the tolerance and protein...
|
|
|
5773577 |
Products comprising substrates capable of enzymatic cross-linking
Polymers are provided comprising protein polymers comprising blocks of repeating units and sequences comprising amino acids, individually or in defined sequences, capable of enzyme catalyzed...
|
|
|
5719031 |
Dye labeled polymers as reagents for measuring polymer degradation
This invention relates to polymers labeled with fluorescent dye to the point that significant fluorescence quenching occurs, such that degradation of the polymer results in fluorescence...
|
|
|
5712250 |
Product for inhibition of human rotavirus infection
An enteral nutritional product containing either bovine κ-casein or human κ-casein at a concentration greater than that found in human or bovine milk and sufficient to inhibit infection of...
|
|
|
5710044 |
Plasmid for expressing phosphorylated recombinant proteins in a bacterial system
The present invention provides a plasmid containing a promoter sequence, a nucleotide sequence encoding an exogenous protein, and a nucleotide sequence encoding an enzyme capable of modifying the...
|
|
|
5707968 |
Inhibition of attachment of H.influenzae to human cells
The attachment of H. influenzae to human cells, such as oropharyngeal cells, may be inhibited by native human β-casein, a recombinant form of human β-casein, and hydrolysates of both. The human...
|
|
|
5703212 |
Preventive for circulatory diseases
A preventive for circulatory diseases which can prevent the onset of circulatory diseases, particularly cerebral stroke, without causing adverse effects such as blood-pressure fluctuation. The...
|
|
|
5683984 |
Enteral tube feeding composition with a native micellar casein protein component
An enteral composition of protein, glucides, lipids and minerals, which is suitable for tube feeding, employs native micellar casein as the protein. The composition is prepared by obtaining native...
|
|
|
5681586 |
Enzyme-modified soy and soy/casein combination healing compositions
A pharmaceutical composition comprising an improved modified protein sol is used for treating and enhancing the healing of arthritis and cutaneous acne. Prior to being modified, a protein is...
|
|
|
5643880 |
Product for inhibition of attachment of H. influenzae to human cells
The attachment of H. influenzae to human cells, such as oropharyngeal cells, may be inhibited by native human β-casein, a recombinant form of human β-casein, and hydrolysates of both. The human...
|
|
|
5578577 |
Method for storing labile proteins
The present invention relates to improved specific binding assay methods, kits and devices utilizing chromatographically mobile specific binding reagents labelled with colloidal particles. Specific...
|
|
|
5576300 |
Method for inhibition of human rotavirus infection
A method of preventing or treating infection by human rotavirus by administering an enteral nutritional product containing either bovine κ-casein or human κ-casein at a concentration greater than...
|
|
|
5538952 |
Inhibition of infection of mammalian cells by respiratory syncytial virus
The infection of mammalian cells by RSV may be inhibited by native human β-casein, a recombinant form of human β-casein, and hydrolysates of both. The human β-casein or hydrolysate may be...
|
|
|
5523293 |
Soy protein-based thermoplastic composition for preparing molded articles
The invention provides biodegradable, thermoplastic compositions made of the reaction product of soybean protein and a carbohydrate filler, a reducing agent, a plasticizer, water, and optional...
|
|
|
5506209 |
Product for inhibition of infection of mammalian cells by respiratory syncytial virus
The infection of mammalian cells by RSV may be inhibited by native human β-casein, a recombinant form of human β-casein, and hydrolysates of both. The human β-casein or hydrolysate may be...
|
|
|
5502163 |
Control of secretion of milk
A protein which inhibits milk secretion by lactating cows and which is present in the second (2A) significant peak when a nominally 10-30 KDa fraction of the whey proteins of the milk is resolved...
|